|Articles|June 1, 2017
- Pharmaceutical Executive-06-01-2017
- Volume 37
- Issue 6
Pharmaceutical Executive, June 2017 Issue (PDF)
Click the title above to open the Pharmaceutical Executive June 2017 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 8 years ago
Pharm Exec's Top 50 Companies 2017over 8 years ago
Navigating Through Disruption: A Pharma 50 Viewover 8 years ago
Tips for Success from a Big Pharma Leaderover 8 years ago
The Quest for Meaningful Pharma-Patient Dialogueover 8 years ago
Executive Roundtable: Where is Your Physician?over 8 years ago
Talent That Takes You into the Futureover 8 years ago
Europe: A Long Summer of Drug Pricing Tensionover 8 years ago
Gottlieb Takes Reins at FDA, Big Issues Loomover 8 years ago
Country Report: TaiwanNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Bristol Myers Squibb Enters $1.5 Billion Definitive Agreement Acquiring Orbital Therapeutics
2
Most Favored Nation Order: Legal Battles, Market Shifts, and the Future of Drug Pricing Reform
3
FDA Approves Libtayo for Immunotherapy for Adjuvant Treatment of Cutaneous Squamous Cell Carcinoma
4
Novo Nordisk Enters $4.7 Billion Definitive Agreement with Akero Therapeutics
5
